Clinical Trials Browser

Phase 2 × pirfenidone × Head & Neck × Clear all

NCT06142318 2023-11-21

Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck